Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Aggen, MD, PhD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Baptist Alliance Mci
Miami, Florida, United States
Active, not recruiting - Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
Recruiting - Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
Recruiting - Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
Recruiting - Memorial Sloan Kettering -Nassau
Commack, New York, United States
Recruiting - Memorial Sloan Kettering Westchester
Harrison, New York, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Memorial Sloan Kettering Nassau
Rockville Centre, New York, United States
Recruiting - Lehigh Valley Health Network (data Collection Only)
Allentown, Pennsylvania, United States
Completed - University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Jun 2022
- Primary completion
- 30 Jun 2027
- Completion
- 30 Jun 2027
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 23
- Registry id
- NCT05239624
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.